Navigation Links
Mesenchymal Stem Cells Mobilize Body’s Own Healing Cells According to New Research Published in STEM CELLS Translational Medicine
Date:12/21/2012

Durham, NC (PRWEB) December 21, 2012

Mesenchymal (MSC) stem cells send out “homing signals” that recruit other stem cells and mobilize them to heal wounds, researchers at the Chicago Medical School at Rosalind Franklin University of Medicine and Science have discovered. MSC stem cells are better suited to initiating the healing process rather than repairing tissue damage themselves, the researchers explain in an article in the current issue of Stem Cells Translational Medicine.

Scientists Daniel Peterson and Laura Shin used MSC cells extracted from human bone marrow and grafted them into wounds of healthy mice and mice with diabetes. Mice in both groups each had two separate wounds to better allow the researchers to study the precise role the cells played in healing.

Some mice in each group received MSC cells in one wound while others did not receive the cells at all.

After studying the differences in healing, signaling and cell populations in the mice, Peterson and Shin learned that both normal and impaired mice given MSC cells healed more quickly, even in wounds that did not receive direct MSC cell grafts.

“The mice that received MSC cells demonstrated a systemic response,” Peterson said. “This suggests that the key to repairing injured tissue does not hinge on where you place the MSC cells in the body, but on learning exactly how the MSC cells recruit their counterparts already in the body.”

Researchers have investigated the behavior of MSC cells in a wide range of clinical trials including studies related to Crohn’s disease, Type 1 diabetes, bone defects and heart muscle disease. However, although MSC cells have come to be regarded as a “magic bullet” for tissue repair, no one until now has been able to explain how they do the job.

Discovering more about the signals MSC cells use to trigger the body’s own stem cells to heal could lead to new cell-free therapies, Peterson said. For example, scientists could develop treatments using small molecules or drugs as an alternative to costly cell-mediated therapies.

“These findings broaden our view of therapeutic targets to include the host response,” he said. “The improvement in impaired and normal wound healing has significant clinical relevance for all wounds, chronic and acute.”

“This study indicates that signals within the wound bed may be activated after engraftment, suggesting that controlling mobilization is a key to success in future therapies,” said Anthony Atala, MD, Editor of Stem Cells Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.

Peterson and Shin are stem cell biologists at the Chicago Medical School, one of five schools and colleges at Rosalind Franklin University of Medicine and Science in North Chicago, IL, where Peterson directs the Center for Stem Cell and Regenerative Medicine. Their study was supported with funds from the U.S. Department of Energy, an American Diabetes Association Clinician Scientist Training Grant, and in part by an Intramural Award from Rosalind Franklin University of Medicine and Science.
###

The full article, “Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells,” can be accessed at http://www.StemCellsTM.com.

About STEM CELLS Translational Medicine: STEM CELLS TRANSLATIONAL MEDICINE (SCTM), published by AlphaMed Press, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS® (http://www.StemCells.com), celebrating its 30th anniversary in 2012, is the world's first journal devoted to this fast paced field of research. The Oncologist® (http://www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 18th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10263160.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Mesenchymal Stem Cells Have New Cell Culture Environment
2. New method for producing precursor of neurons, bone and other important tissues from stem cells
3. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
4. Notre Dame researchers develop paint-on solar cells
5. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
6. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
7. In solar cells, tweaking the tiniest of parts yields big jump in efficiency
8. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
9. Scientists Discover How a Bacterial Pathogen Breaks Down Barriers to Enter and Infect Cells
10. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
11. Study dusts sugar coating off little-known regulation in cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... June 22, 2016 Research and Markets has ... report to their offering. ... 2014 from $29.3 billion in 2013. The market is expected to ... from 2015 to 2020, increasing from $50.6 billion in 2015 to ... forecasts during the forecast period (2015 to 2020) are discussed. As ...
(Date:6/22/2016)... 2016   ViaCyte, Inc. , a privately-held regenerative ... replacement therapy for the treatment of diabetes in clinical-stage ... Meeting.  ISSCR 2016, the Global Stem Cell Event, is ... in San Francisco.    ... follows:Event: , Focus Session: Tools for Basic and Applied ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):